The table below shows NEUROCRINE BIOSCIENCES INC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
-
-
-
-
-
-
Cost of revenue
$13.80M
$14.00M
$11.30M
$9.20M
$8.00M
$9.20M
Gross profit
-
-
-
-
-
-
R&D
-
-
-
-
-
-
SG&A
NBIX annual revenue (10-K history)
NEUROCRINE BIOSCIENCES INC reported annual revenue of $2.86B for fiscal year 2025. That is up 21.4% from $2.36B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $15.00M (FY 2016) to $2.86B. Figures come from the company's audited annual reports as filed with the SEC.
